(Q37896760)

25 August 2017

1 reference

title

Smart medication through combination of synthetic biology and cell microencapsulation (English)

1 reference

25 August 2017

1 reference

1 reference

3

Martin Fussenegger

1 reference

25 August 2017

Simon Ausländer

1

1 reference

25 August 2017

Markus Wieland

series ordinal

2

1 reference

25 August 2017

language of work or name

1 reference

24 June 2011

1 reference

25 August 2017

published in

Metabolic Engineering

1 reference

25 August 2017

volume

14

1 reference

25 August 2017

issue

3

1 reference

25 August 2017

page(s)

252-260

1 reference

Pig pancreatic islet transplantation into spontaneously diabetic dogs

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

The Lutropin/Choriogonadotropin Receptor, A 2002 Perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Neuroprotective gene therapy for Huntington's disease using a polymer encapsulated BHK cell line engineered to secrete human CNTF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Adapting proteostasis for disease intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Gene regulation by tetracyclines. Constraints of resistance regulation in bacteria shape TetR for application in eukaryotes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Designing transcription factor architectures for drug discovery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Inducing Tolerance to a Soluble Foreign Antigen by Encapsulated Cell Transplants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: results of a phase I study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Uric acid nephrolithiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Improvement of the monitoring and biosafety of encapsulated cells using the SFGNESTGL triple reporter system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

SEMIPERMEABLE MICROCAPSULES

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Therapeutic applications of polymeric artificial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

In vitro and in vivo performance of porcine islets encapsulated in interfacially photopolymerized poly(ethylene glycol) diacrylate membranes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Reprogramming cellular behavior with RNA controllers responsive to endogenous proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

A synchronized quorum of genetic clocks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Tetracycline-reversible silencing of eukaryotic promoters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Hydrogels for tissue engineering: scaffold design variables and applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Delivery of immunostimulatory monoclonal antibodies by encapsulated hybridoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Evaluation of alginate purification methods: effect on polyphenol, endotoxin, and protein contamination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Boar spermatozoa encapsulated in barium alginate membranes: a microdensitometric evaluation of some enzymatic activities during storage at 18 degrees C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

A novel system for trigger-controlled drug release from polymer capsules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Streptogramin-based gene regulation systems for mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Controlling transgene expression in subcutaneous implants using a skin lotion containing the apple metabolite phloretin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Tight control of gene expression in mammalian cells by tetracycline-responsive promoters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

An engineered L-arginine sensor of Chlamydia pneumoniae enables arginine-adjustable transcription control in mammalian cells and mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Successful allotransplantation of microencapsulated parathyroids in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Isotransplantation of microencapsulated parathyroid tissue in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Microcapsules and microcarriers for in situ cell delivery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Cell encapsulation using biopolymer gels for regenerative medicine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Status of tumor markers in epithelial ovarian cancer has there been any progress? A review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Neurotoxicity of β-amyloid protein: oligomerization, channel formation, and calcium dyshomeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

A designer network coordinating bovine artificial insemination by ovulation-triggered release of implanted sperms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Self-sufficient control of urate homeostasis in mice by a synthetic circuit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Synthetic biology: applications come of age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Control of dopamine-secretion by Tet-Off system in an in vivo model of parkinsonian rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

BioLogic gates enable logical transcription control in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Altered uric acid levels and disease states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Microencapsulated islets as bioartificial endocrine pancreas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Dyskinesia after fetal cell transplantation for parkinsonism: a PET study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Immunostimulatory monoclonal antibodies for cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Cancer regression in patients after transfer of genetically engineered lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

The cumate gene-switch: a system for regulated expression in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Antiprogestin-controllable transgene regulation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Cytomedical therapy for IgG1 plasmacytosis in human interleukin-6 transgenic mice using hybridoma cells microencapsulated in alginate-poly(L)lysine-alginate membrane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Bioactive cell-hydrogel microcapsules for cell-based drug delivery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Cell encapsulation: promise and progress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

The second wave of synthetic biology: from modules to systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

The TetR family of transcriptional repressors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Distributed biological computation with multicellular engineered networks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

A universal RNAi-based logic evaluator that operates in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Alginate type and RGD density control myoblast phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Cell therapy with encapsulated xenogeneic tumor cells secreting beta-endorphin for treatment of peripheral pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Treatment of type I diabetes using encapsulated islets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Long-term reversal of diabetes by the injection of immunoprotected islets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Cyotomedical therapy for insulinopenic diabetes using microencapsulated pancreatic beta cell lines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Multichromatic control of gene expression in Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Robust multicellular computing using genetically encoded NOR gates and chemical 'wires'.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Alginate-encapsulated producer cells: a potential new approach for the treatment of malignant brain tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

A synthetic low-frequency mammalian oscillator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

A tunable synthetic mammalian oscillator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

A synthetic-natural hybrid oscillator in human cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Semen controlled-release capsules allow a single artificial insemination in sows

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Vitamin H-regulated transgene expression in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Synthetic ecosystems based on airborne inter- and intrakingdom communication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Engineering of synthetic mammalian gene networks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Macrolide-based transgene control in mammalian cells and mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

A biotin-triggered genetic switch in mammalian cells and mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

A synthetic mammalian electro-genetic transcription circuit.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Design of high-throughput-compatible protocols for microencapsulation, cryopreservation and release of bovine spermatozoa.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

A synthetic mammalian gene circuit reveals antituberculosis compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Ligand-dependent regulatory RNA parts for Synthetic Biology in eukaryotes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Higher-order cellular information processing with synthetic RNA devices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

The viability and regeneration of artificial cell microencapsulated rat hepatocyte xenograft transplants in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Hyperuricemia and urate nephropathy in urate oxidase-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

The cancer secretome: a reservoir of biomarkers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Programmed population control by cell-cell communication and regulated killing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

Transplantation of microencapsulated genetically modified xenogeneic cells augments angiogenesis and improves heart function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2011.06.003

10.1016/J.YMBEN.2011.06.003

7 January 2021

Identifiers

DOI

1 reference

25 August 2017

1 reference